MY FELINE

Brand Owner Address Description
MYFELINE Liu, Qing Yard 63, Youyi Street Erbaihu Village, Huangtuzhuang Town Langfang 065200 China MY FELINE;Lancets; Abdominal belts; Aerosol dispensers for medical use; Blood glucose meter; Blood pressure monitors; Clinical thermometers; Face masks for use by health care providers; Health monitoring devices consisting of blood pressure monitors, thermometers and pedometers; Heart rate monitors for sports activities; Hot or cold therapy wraps; Infrared thermometers for medical purposes; Medical devices, namely, pulse oximeters; Physical exercise apparatus, for medical purposes; Sanitary masks for dust prevention for medical purposes; Sanitary masks for medical purposes; Supports for general medical use; Tips for crutches; Traction apparatus for medical purposes; Vibrating apparatus used to stimulate muscles and increase strength and physical performance for health and medical purposes;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention relates to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins; to canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF nucleic acid molecules, including those that encode canine interleukin-4, canine or feline Flt-3 ligand, canine or feline CD40, canine or feline CD154, canine interleukin-5, canine interleukin-13, feline interferon alpha, and/or feline GM-CSF proteins, respectively; to antibodies raised against such proteins; and to inhibitory compounds that regulate such proteins. The present invention also includes methods to identify and obtain such proteins, nucleic acid molecules, antibodies, and inhibitory compounds. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies and/or inhibitory compounds as well as the use of such therapeutic compositions to regulate an immune response in an animal.